InvestorsHub Logo
Followers 6
Posts 182
Boards Moderated 0
Alias Born 09/16/2010

Re: None

Thursday, 10/29/2020 2:46:18 PM

Thursday, October 29, 2020 2:46:18 PM

Post# of 457666
Is it possible to give license to aducanumab when those adverse effects happen to patients?

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545921/

Hope those guys read
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News